fda novavax - Search News

News

FDA approves Moderna’s next-generation COVID-19 vaccine

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

Rheumatology Advisor · 2d

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

STAT · 6d

FDA approves a next-generation Covid vaccine from Moderna, with restrictions

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing Covid shot does not currently face.

Medical Marketing & Media10d

Rx Rundown: BioMarin, Novavax, CellCentric and more

CRISPR Therapeutics announced an agreement with Sirius Therapeutics to develop and commercialize small interfering RNA (siRNA) therapies. Under the deal, CRISPR will pay $25 million in cash and $70 ...

Healio3d

FDA approves Moderna’s lower-dose COVID-19 vaccine for some

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...

KTBS 32d

Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results